Geographic Reach Genepharm supplies certified generics to more than 90 countries, indicating a broad international footprint and potential for cross-border distribution partnerships, licensing, or co-development opportunities in diverse markets.

Oncology and Cardiology Focus With dedicated production lines for conventional and oncological solids and active collaboration potential in oncology and cardiology, there are clear upsell or licensing opportunities for high-demand therapeutic areas.

Manufacturing Scale A privately owned 15,000 m2 facility capable of producing hundreds of millions of tablets and millions of capsules demonstrates strong supply capacity and reliability for volume contracts, private label, or distributed generics programs.

Strategic Partnerships Recent and past partnerships and ownership changes signal openness to licensing, technology transfer, and regional expansion deals, especially in the Middle East, GCC, and neighboring markets.

Regulatory and Quality Alignment EU GMP-compliant operations and diversified therapeutic portfolio position Genepharm as a compliant supplier for global distributors, hospital networks, and regional distributors seeking certified generics.